×

11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors and uses thereof

  • US 8,871,208 B2
  • Filed: 12/02/2010
  • Issued: 10/28/2014
  • Est. Priority Date: 12/04/2009
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for treating a patient suffering from chronic inflammation or neuropathic pain, comprising administering to the patient an effective amount of a selective inhibitor of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme activity, wherein the inhibitor is a compound of formula (I):

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×